AMZN
Amazon.com, Inc.
AMZN has the edge over TRIP overall, supported by stronger fundamentals and lower modeled downside.
TRIP
Tripadvisor, Inc.
TRIP trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
TRIP Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
TRIP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
TRIP PE Valuation
TRIP has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over TRIP on the outlook, with more favorable earnings and revenue expectations.
TRIP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect TRIP's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over TRIP on earnings quality, reporting a profit while its opponent remains loss making.
TRIP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.61 | — |
| Q3 2026 | -$3.07 | -565% |
| Q2 2026 | $0.02 | -96% |
| Q1 2026 | $0.11 | -72% |
| Q4 2025 | $0.31 | +675% |
| Q3 2025 | $0.66 | +164% |
| Q2 2025 | $0.50 | +194% |
| Q1 2025 | $0.39 | +129% |
| Q4 2024 | $0.04 | -50% |
TRIP has swung to a loss: it lost $3.07 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over TRIP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over TRIP on profitability, with a higher operating margin.
TRIP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $436.4M | -21% |
| Q2 2026 | $441.9M | -16% |
| Q1 2026 | $382.4M | -3.9% |
| Q4 2025 | $411M | 0% |
| Q3 2025 | $553M | +3.9% |
| Q2 2025 | $529M | +6.4% |
| Q1 2025 | $398M | +0.8% |
| Q4 2024 | $411M | +5.4% |
TRIP's revenue has slid since its 2025 peak: $436M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -77% | -90 points |
| Q2 2026 | 8.6% | -2.6 points |
| Q1 2026 | -6.6% | -2.8 points |
| Q4 2025 | -8.3% | -8.3 points |
| Q3 2025 | 13% | -0.5 points |
| Q2 2025 | 11% | +3.9 points |
| Q1 2025 | -3.8% | 0 points |
| Q4 2024 | 0% | -8.2 points |
TRIP's operating margin was −77% last quarter, down 90 points from the same quarter a year ago, near the bottom of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
TRIP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$136.7M | -647% |
| Q2 2026 | $137.7M | -22% |
| Q1 2026 | $101.3M | +22% |
| Q4 2025 | -$122M | -$96M |
| Q3 2025 | $25M | +$88M |
| Q2 2025 | $177M | +392% |
| Q1 2025 | $83M | -33% |
| Q4 2024 | -$26M | +$9M |
TRIP has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
TRIP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -384K shares |
| 1 year | -5% | -6.2M shares |
| 3 years | -18% | -25.8M shares |
| 5 years | -19% | -27M shares |
| Available history | -16% | -23.2M shares |
TRIP has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $50M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $25M |
| Q3 2023 | — |
| Q4 2020 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TRIP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -1.3x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
TRIP has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
TRIP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 9.6 | Oversold |
TRIP's weekly RSI is 32 (neutral) and its Stochastic is 10 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over TRIP on valuation relative to its sector.
TRIP PE vs Consumer Cyclical Sector
| Metric | TRIP | Sector median | Relative |
|---|---|---|---|
| PE | 461x | 18x | 2,458% above |
| PE % | 96 | 47 | 49 pts above |
TRIP has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over TRIP on trend strength, trading above more of its moving averages.
TRIP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.47 | 14% below |
| 20 week MA | $10.4 | 30% below |
| 50 week MA | $11.3 | 36% below |
| 100 week MA | $13.4 | 46% below |
| 200 week MA | $16.0 | 55% below |
TRIP is in a downtrend: it's below all five of its weekly moving averages, and 55% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over TRIP on returns for 2026, with the stronger performance.
TRIP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.3 | $26.0 | -14% |
| 2021 | $26.0 | $27.3 | +4.8% |
| 2022 | $27.3 | $17.9 | -35% |
| 2023 | $17.9 | $21.5 | +21% |
| 2024 | $21.5 | $14.6 | -32% |
| 2025 | $14.6 | $14.1 | -3.2% |
| 2026 YTD | $14.1 | $7.25 | -49% |
TRIP has finished lower in four of the last six years. It's down 49% so far in 2026.